Revolution Medicine has wowed investors and analysts by announcing dazzling data from its Phase III RASolute 302 trial ...
CStone Pharmaceuticals ('CStone,' HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, immunology, inflammation, and other key ...
A Cell Perspective argues that generative AI models could help tackle cancer’s multiscale, multimodal complexity by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results